OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 68 filers reported holding OCULAR THERAPEUTIX INC in Q2 2018. The put-call ratio across all filers is 0.35 and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $6,000 | +100.0% | 700 | 0.0% | 0.00% | – |
Q1 2020 | $3,000 | 0.0% | 700 | 0.0% | 0.00% | – |
Q4 2019 | $3,000 | +50.0% | 700 | 0.0% | 0.00% | – |
Q3 2019 | $2,000 | -33.3% | 700 | 0.0% | 0.00% | – |
Q2 2019 | $3,000 | 0.0% | 700 | 0.0% | 0.00% | – |
Q1 2019 | $3,000 | 0.0% | 700 | 0.0% | 0.00% | – |
Q4 2018 | $3,000 | -40.0% | 700 | 0.0% | 0.00% | – |
Q3 2018 | $5,000 | 0.0% | 700 | 0.0% | 0.00% | – |
Q2 2018 | $5,000 | 0.0% | 700 | 0.0% | 0.00% | – |
Q1 2018 | $5,000 | -16.7% | 700 | -50.0% | 0.00% | – |
Q4 2017 | $6,000 | +50.0% | 1,400 | +100.0% | 0.00% | – |
Q3 2017 | $4,000 | -33.3% | 700 | 0.0% | 0.00% | – |
Q2 2017 | $6,000 | 0.0% | 700 | 0.0% | 0.00% | – |
Q1 2017 | $6,000 | -68.4% | 700 | -68.2% | 0.00% | -100.0% |
Q4 2016 | $19,000 | 0.0% | 2,200 | -18.5% | 0.00% | 0.0% |
Q3 2016 | $19,000 | +533.3% | 2,700 | +285.7% | 0.00% | – |
Q2 2016 | $3,000 | -57.1% | 700 | 0.0% | 0.00% | – |
Q1 2016 | $7,000 | 0.0% | 700 | 0.0% | 0.00% | – |
Q4 2015 | $7,000 | – | 700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SUMMER ROAD LLC | 6,122,089 | $31,590 | 100.00% |
Opaleye Management Inc. | 5,780,000 | $29,824,800 | 7.13% |
DELTEC ASSET MANAGEMENT LLC | 1,974,797 | $10,189,953 | 2.23% |
Lynwood Capital Management Inc. | 262,500 | $1,354,500 | 1.72% |
Endurant Capital Management LP | 368,438 | $1,901,140 | 1.66% |
Knoll Capital Management, LLC | 200,000 | $1,032,000 | 1.25% |
Knoll Capital Management, LLC | 95,800 | $814,300 | 0.99% |
SECTORAL ASSET MANAGEMENT INC | 802,680 | $4,141,829 | 0.69% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 300,977 | $1,553,041 | 0.22% |
Cormorant Asset Management, LP | 645,000 | $3,328,200 | 0.19% |